Top-of-Funnel Recruitment
End-to-End Enrollment
Broadening Access: 1nHealth was tasked by a sponsor to recruit patients for an observational study representing non-Caucasian genome (Black, Latino, Asian, MENA, NHPI, Native American) who were historically underrepresented in biomedical research. Participation is remote, but they must submit DNA and blood samples as well as connect their electronic medical and health records.
Expanding Patient Voices: Basket studies enrolling historically underrepresented populations enable trials to capture diverse genetic, environmental, and cultural factors. This approach leads to a better understanding of treatment efficacy across demographics, and medical breakthroughs that truly serve all patients.
Tried & Tested: Because we A/B tested and found that messaging which spoke to individuals as part of a larger community and used compelling imagery and compliant targeting methods, we were able to drive high-intent consents at scale.
Finishing Strong: This study is still ongoing, but our enrollment is on track to be completed three months ahead of schedule. As of February 2025, we’ve consented 1,878 patients from a total of 19,985 qualified referrals—good for a 9.4% ICF rate.
